Market Cap | 4.91B | P/E | - | EPS this Y | -0.80% | Ern Qtrly Grth | - |
Income | -113.8M | Forward P/E | 11.52 | EPS next Y | 21.50% | 50D Avg Chg | 7.00% |
Sales | 4.43B | PEG | 1.02 | EPS past 5Y | -14.64% | 200D Avg Chg | 3.00% |
Dividend | 3.00% | Price/Book | 1.02 | EPS next 5Y | 10.00% | 52W High Chg | -17.00% |
Recommedations | 2.00 | Quick Ratio | 0.87 | Shares Outstanding | 136.42M | 52W Low Chg | 18.00% |
Insider Own | 0.32% | ROA | 1.20% | Shares Float | 135.61M | Beta | 0.49 |
Inst Own | 97.83% | ROE | -2.42% | Shares Shorted/Prior | 4.26M/4.37M | Price | 36.30 |
Gross Margin | 35.93% | Profit Margin | -2.81% | Avg. Volume | 1,186,327 | Target Price | 35.67 |
Oper. Margin | 4.22% | Earnings Date | Aug 2 | Volume | 868,674 | Change | -0.14% |
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Canaccord Genuity | Buy | Sep 30, 24 |
Jefferies | Hold | Sep 23, 24 |
Piper Sandler | Overweight | Jul 11, 24 |
Piper Sandler | Overweight | Jun 13, 24 |
Canaccord Genuity | Buy | Apr 12, 24 |
Piper Sandler | Overweight | Apr 8, 24 |
JP Morgan | Overweight | Feb 28, 24 |
Piper Sandler | Overweight | Nov 17, 23 |
JP Morgan | Overweight | Aug 9, 23 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Willis Robert | EVP & CHRO EVP & CHRO | Nov 24 | Buy | 31.01 | 5,550 | 172,106 | 19,105 | 11/27/23 |
Ives Alison | EVP & Chief Scientif.. EVP & Chief Scientific Officer | Nov 16 | Buy | 29.34 | 2,040 | 59,854 | 10,380 | 11/17/23 |
Ives Alison | EVP & Chief Scientif.. EVP & Chief Scientific Officer | Oct 06 | Option | 30.46 | 738 | 22,479 | 9,078 | 10/10/23 |
Manzone Albert | Director Director | Aug 15 | Option | 38.88 | 5,478 | 212,985 | 5,478 | 08/17/23 |
Ives Alison | EVP & Chief Scientif.. EVP & Chief Scientific Officer | Jul 07 | Option | 32.63 | 920 | 30,020 | 8,611 | 07/10/23 |
HANSON KYLE | EVP & General Counse.. EVP & General Counsel | Jul 07 | Option | 32.63 | 12,409 | 404,906 | 9,552 | 07/10/23 |
Parker Geoffrey M. | Director Director | Jun 13 | Buy | 33.0637 | 10,000 | 330,637 | 25,879 | 06/14/23 |
Andersen Svend | EVP & President CHCI EVP & President CHCI | May 23 | Buy | 33.4146 | 2,900 | 96,902 | 68,741 | 05/25/23 |
KESSLER MURRAY S | CEO CEO | May 11 | Sell | 35.7526 | 197,646 | 7,066,358 | 2,668 | 05/15/23 |
Dillard James E III | EVP & President CSCA EVP & President CSCA | Mar 10 | Sell | 35.701 | 9,000 | 321,309 | 25,130 | 03/14/23 |
Farrington Thomas | EVP and CIO EVP and CIO | Mar 13 | Sell | 35.58 | 3,723 | 132,464 | 2,823 | 03/14/23 |
Ives Alison | EVP & Chief Scientif.. EVP & Chief Scientific Officer | Mar 07 | Option | 37.71 | 1,746 | 65,842 | 8,201 | 03/09/23 |
Farrington Thomas | EVP and CIO EVP and CIO | Mar 06 | Option | 37.71 | 2,406 | 90,730 | 7,705 | 03/08/23 |
Parker Geoffrey M. | Director Director | Mar 06 | Buy | 38.054 | 5,000 | 190,270 | 15,879 | 03/07/23 |
Quinn Grainne | EVP, Chief Medical O.. EVP, Chief Medical Officer | Dec 16 | Sell | 31.65 | 2,368 | 74,947 | 9,118 | 12/20/22 |
Karaboutis Adriana | Director Director | May 17 | Option | 38.57 | 6,599 | 254,523 | 17,046 | 05/19/22 |
Doyle Katherine C. | Director Director | May 17 | Option | 38.57 | 6,599 | 254,523 | 9,530 | 05/19/22 |
O'Connor Donal | Director Director | May 17 | Option | 38.57 | 6,599 | 254,523 | 20,054 | 05/19/22 |
Mann Erica L | Director Director | May 17 | Option | 38.57 | 6,599 | 254,523 | 12,289 | 05/19/22 |
ASHFORD ORLANDO D | Director Director | May 17 | Option | 38.57 | 6,599 | 254,523 | 8,150 | 05/19/22 |
Samuels Theodore R. II | Director Director | May 17 | Option | 38.57 | 6,599 | 254,523 | 26,693 | 05/19/22 |
Alford Bradley A | Director Director | May 17 | Option | 38.57 | 6,599 | 254,523 | 30,577 | 05/19/22 |
Parker Geoffrey M. | Director Director | May 17 | Option | 38.57 | 6,599 | 254,523 | 14,829 | 05/19/22 |
KINDLER JEFFREY B | Director Director | May 17 | Option | 38.57 | 6,599 | 254,523 | 17,574 | 05/19/22 |
SILCOCK RAYMOND | EVP, Chief Financial.. EVP, Chief Financial Officer | Apr 05 | Option | 36.27 | 3,963 | 143,738 | 60,955 | 04/07/22 |
Farrington Thomas | EVP and CIO EVP and CIO | Mar 14 | Sell | 37.18 | 26,744 | 994,342 | 03/16/22 | |
Willis Robert | EVP & CHRO EVP & CHRO | Mar 04 | Option | 37.23 | 5,012 | 186,597 | 9,760 | 03/08/22 |
Janish Ronald Craig | EVP, Gbl Ops & SC &.. EVP, Gbl Ops & SC & CTO | Mar 04 | Option | 37.23 | 5,410 | 201,414 | 20,559 | 03/08/22 |
Janish Ronald Craig | EVP, Gbl Ops & SC &.. EVP, Gbl Ops & SC & CTO | Mar 04 | Sell | 36.73 | 3,954 | 145,230 | 15,686 | 03/08/22 |
Farrington Thomas | EVP and CIO EVP and CIO | Mar 04 | Option | 37.23 | 4,424 | 164,706 | 25,185 | 03/08/22 |
ASHFORD ORLANDO D | Director Director | Mar 04 | Option | 37.23 | 2,984 | 111,094 | 2,984 | 03/08/22 |
KINGMA TODD W | Executive VP, Genera.. Executive VP, General Counsel | Mar 04 | Option | 37.23 | 8,911 | 331,757 | 46,677 | 03/08/22 |
Dillard James E III | EVP & President CSCA EVP & President CSCA | Mar 04 | Option | 37.23 | 7,002 | 260,684 | 24,148 | 03/08/22 |
Quinn Grainne | EVP, Chief Medical O.. EVP, Chief Medical Officer | Mar 04 | Option | 37.23 | 3,862 | 143,782 | 12,310 | 03/08/22 |
KESSLER MURRAY S | CEO CEO | Mar 04 | Option | 37.23 | 49,328 | 1,836,481 | 127,489 | 03/08/22 |
SILCOCK RAYMOND | EVP, Chief Financial.. EVP, Chief Financial Officer | Mar 04 | Option | 37.23 | 8,502 | 316,529 | 58,796 | 03/08/22 |
Andersen Svend | EVP & President CHCI EVP & President CHCI | Mar 04 | Option | 37.23 | 8,911 | 331,757 | 41,372 | 03/08/22 |
Dillard James E III | EVP & President CSCA EVP & President CSCA | Feb 07 | Option | 36.95 | 4,297 | 158,774 | 14,900 | 02/09/22 |
KESSLER MURRAY S | CEO CEO | Mar 09 | Option | 41.04 | 30,446 | 1,249,504 | 49,164 | 03/09/21 |
Kochan Sharon | EVP & President Rx EVP & President Rx | Mar 09 | Option | 41.04 | 4,057 | 166,499 | 38,748 | 03/09/21 |
Sorota Richard S | EVP & President CSCA EVP & President CSCA | Mar 09 | Option | 41.04 | 2,540 | 104,242 | 10,053 | 03/09/21 |
Farrington Thomas | EVP and CIO EVP and CIO | Mar 09 | Option | 41.04 | 2,730 | 112,039 | 18,468 | 03/09/21 |
Dillard James E III | EVP, Chief Scientifi.. EVP, Chief Scientific Officer | Mar 09 | Option | 41.04 | 4,322 | 177,375 | 11,173 | 03/09/21 |
Willis Robert | EVP & CHRO EVP & CHRO | Mar 09 | Option | 41.24 | 2,780 | 114,647 | 4,788 | 03/09/21 |
Quinn Grainne | EVP, Chief Medical O.. EVP, Chief Medical Officer | Mar 09 | Option | 41.04 | 2,279 | 93,530 | 7,299 | 03/09/21 |
Janish Ronald Craig | EVP, Gbl Ops & SC &.. EVP, Gbl Ops & SC & CTO | Mar 09 | Option | 41.04 | 3,339 | 137,033 | 14,835 | 03/09/21 |